211 related articles for article (PubMed ID: 21441474)
1. Virus-host interactions in HIV pathogenesis: directions for therapy.
Levy JA
Adv Dent Res; 2011 Apr; 23(1):13-8. PubMed ID: 21441474
[TBL] [Abstract][Full Text] [Related]
2. Elevated Expression of miR-19b Enhances CD8
Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
Front Immunol; 2018; 9():3140. PubMed ID: 30687333
[TBL] [Abstract][Full Text] [Related]
3. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
mBio; 2017 May; 8(3):. PubMed ID: 28465428
[TBL] [Abstract][Full Text] [Related]
4. HIV pathogenesis: knowledge gained after two decades of research.
Levy JA
Adv Dent Res; 2006 Apr; 19(1):10-6. PubMed ID: 16672543
[TBL] [Abstract][Full Text] [Related]
5. Cellular resistance to HIV-1 infection in target cells coincides with a rapid induction of X-DING-CD4 mRNA: indication of the unique host innate response to virus regulated through function of the X-DING-CD4 gene.
Shilpi RY; Sachdeva R; Simm M
Innate Immun; 2012 Aug; 18(4):563-70. PubMed ID: 22042911
[TBL] [Abstract][Full Text] [Related]
6. Cell-to-Cell Spread of HIV and Viral Pathogenesis.
Law KM; Satija N; Esposito AM; Chen BK
Adv Virus Res; 2016; 95():43-85. PubMed ID: 27112280
[TBL] [Abstract][Full Text] [Related]
7. Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection.
Hu H; Nau M; Ehrenberg P; Chenine AL; Macedo C; Zhou Y; Daye ZJ; Wei Z; Vahey M; Michael NL; Kim JH; Marovich M; Ratto-Kim S
Blood; 2013 Feb; 121(7):1136-44. PubMed ID: 23258923
[TBL] [Abstract][Full Text] [Related]
8. HIV controllers: a multifactorial phenotype of spontaneous viral suppression.
Thèze J; Chakrabarti LA; Vingert B; Porichis F; Kaufmann DE
Clin Immunol; 2011 Oct; 141(1):15-30. PubMed ID: 21865089
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.
Walker-Sperling VE; Pohlmeyer CW; Veenhuis RT; May M; Luna KA; Kirkpatrick AR; Laeyendecker O; Cox AL; Carrington M; Bailey JR; Arduino RC; Blankson JN
EBioMedicine; 2017 Feb; 16():141-149. PubMed ID: 28159573
[TBL] [Abstract][Full Text] [Related]
10. Harnessing CD8
Warren JA; Clutton G; Goonetilleke N
Front Immunol; 2019; 10():291. PubMed ID: 30863403
[TBL] [Abstract][Full Text] [Related]
11. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
12. Innate immune sensing of HIV infection.
Silvin A; Manel N
Curr Opin Immunol; 2015 Feb; 32():54-60. PubMed ID: 25617674
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Type I Interferon Induction by HIV Infection of T Cells.
Sanchez DJ; Miranda D; Marsden MD; Dizon TM; Bontemps JR; Davila SJ; Del Mundo LE; Ha T; Senaati A; Zack JA; Cheng G
PLoS One; 2015; 10(9):e0137951. PubMed ID: 26375588
[TBL] [Abstract][Full Text] [Related]
14. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
15. Innate immune recognition of HIV-1.
Iwasaki A
Immunity; 2012 Sep; 37(3):389-98. PubMed ID: 22999945
[TBL] [Abstract][Full Text] [Related]
16. Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1.
Colomer-Lluch M; Ruiz A; Moris A; Prado JG
Front Immunol; 2018; 9():2876. PubMed ID: 30574147
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
18. Effects of neutralizing antibodies on escape from CD8+ T-cell responses in HIV-1 infection.
Wikramaratna PS; Lourenço J; Klenerman P; Pybus OG; Gupta S
Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150656
[TBL] [Abstract][Full Text] [Related]
19. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
Belyakov IM; Ahlers JD
Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
